New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
The prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high...
Saved in:
| Main Authors: | V. V. Syvolap, M. P. Gerasko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2014-04-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/24831/22316 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01) -
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
by: Berezin A.E., et al.
Published: (2015-06-01) -
Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report
by: A. A. Nekrasov, et al.
Published: (2023-01-01) -
Joint associations of pre-diabetes, pre-hypertension, and pre-dyslipidemia with cardiovascular and metabolic disease progression
by: Cui Ma, et al.
Published: (2025-08-01) -
Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)